|
1
|
Berk SL and McCabe WR: Meningitis caused
by gram-negative bacilli. Ann Intern Med. 93:253–260.
1980.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Camacho EF, Boszczowski I, Basso M, Jeng
BC, Freire MP, Guimarães T, Teixeira MJ and Costa SF: Infection
rate and risk factors associated with infections related to
external ventricular drain. Infection. 39:47–51. 2011.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Cascio A, Conti A, Sinardi L, Iaria C,
Angileri FF, Stassi G, David T, Versaci A, Iaria M and David A:
Post-neurosurgical multidrug-resistant Acinetobacter baumannii
meningitis successfully treated with intrathecal colistin. A new
case and a systematic review of the literature. Int J Infect Dis.
14:e572–e579. 2010.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Faillace WJ: A no-touch technique protocol
to diminish cerebrospinal fluid shunt infection. Surg Neurol.
43:344–350. 1995.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Tsolaki V, Karvouniaris M, Manoulakas E,
Kotlia P, Karadontas V, Fotakopoulos G, Zakynthinos E and Makris D:
Intraventricular CNS treatment with colistin-tigecycline
combination: A case series. J Crit Care. 47:338–341.
2018.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Laxmi S and Tunkel AR:
Healthcare-associated bacterial meningitis. Curr Infect Dis Rep.
13:367–373. 2011.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Stenehjem E and Armstrong WS: Central
nervous system device infections. Infect Dis Clin North Am.
26:89–110. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Parodi S, Lechner A, Osih R, Vespa P and
Pegues D: Nosocomial enterobacter meningitis: Risk factors,
management, and treatment outcomes. Clin Infect Dis. 37:159–166.
2003.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Falagas ME and Kasiakou SK: Toxicity of
polymyxins: A systematic review of the evidence from old and recent
studies. Crit Care. 10(R27)2006.PubMed/NCBI View
Article : Google Scholar
|
|
10
|
Baiocchi M, Catena V, Zago S, Badolati L
and Baccarin M: Intrathecal colistin for treatment of multidrug
resistant (MDR) Pseudomonas aeruginosa after neurosurgical
ventriculitis. Infez Med. 18:182–186. 2010.PubMed/NCBI
|
|
11
|
Fotakopoulos G, Makris D, Chatzi M,
Tsimitrea E, Zakynthinos E and Fountas K: Outcomes in
meningitis/ventriculitis treated with intravenous or
intraventricular plus intravenous colistin. Acta Neurochir (Wien).
158:603–610; discussion 610. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Foster RL: Reporting guidelines: CONSORT,
PRISMA, and SQUIRE. J Spec Pediatr Nurs. 17:1–2. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Bae JM: A suggestion for quality
assessment in systematic reviews of observational studies in
nutritional epidemiology. Epidemiol Health.
38(e2016014)2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Chusri S, Sakarunchai I, Kositpantawong N,
Panthuwong S, Santimaleeworagun W, Pattharachayakul S, Singkhamanan
K and Doi Y: Outcomes of adjunctive therapy with intrathecal or
intraventricular administration of colistin for post-neurosurgical
meningitis and ventriculitis due to carbapenem-resistant
acinetobacter baumannii. Int J Antimicrob Agents. 51:646–650.
2018.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Shofty B, Neuberger A, Naffaa ME, Binawi
T, Babitch T, Rappaport ZH, Zaaroor M, Sviri G and Paul M:
Intrathecal or intraventricular therapy for post-neurosurgical
gram-negative meningitis: Matched cohort study. Clin Microbiol
Infect. 22:66–70. 2016.PubMed/NCBI View Article : Google Scholar
|
|
16
|
De Bonis P, Lofrese G, Scoppettuolo G,
Spanu T, Cultrera R, Labonia M, Cavallo MA, Mangiola A, Anile C and
Pompucci A: Intraventricular versus intravenous colistin for the
treatment of extensively drug resistant acinetobacter baumannii
meningitis. Eur J Neurol. 23:68–75. 2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Moon C, Kwak YG, Kim BN, Kim ES and Lee
CS: Implications of postneurosurgical meningitis caused by
carbapenem-resistant Acinetobacter baumannii. J Infect Chemother.
19:916–919. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Wang JH, Lin PC, Chou CH, Ho CM, Lin KH,
Tsai CT, Wang JH, Chi CY and Ho MW: Intraventricular antimicrobial
therapy in postneurosurgical gram-negative bacillary meningitis or
ventriculitis: A hospital-based retrospective study. J Microbiol
Immunol Infect. 47:204–210. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tängdén T, Enblad P, Ullberg M and Sjölin
J: Neurosurgical gram-negative bacillary ventriculitis and
meningitis: A retrospective study evaluating the efficacy of
intraventricular gentamicin therapy in 31 consecutive cases. Clin
Infect Dis. 52:1310–1316. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Ziaka M, Markantonis SL, Fousteri M,
Zygoulis P, Panidis D, Karvouniaris M, Makris D and Zakynthinos E:
Combined intravenous and intraventricular administration of
colistin methanesulfonate in critically ill patients with central
nervous system infection. Antimicrob Agents Chemother.
57:1938–1940. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Koch-Weser J, Sidel VW, Federman EB,
Kanarek P, Finer DC and Eaton AE: Adverse effects of sodium
colistimethate. Manifestations and specific reaction rates during
317 courses of therapy. Ann Intern Med. 72:857–868. 1970.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Li J, Nation RL, Turnidge JD, Milne RW,
Coulthard K, Rayner CR and Paterson DL: Colistin: The re-emerging
antibiotic for multidrug-resistant gram-negative bacterial
infections. Lancet Infect Dis. 6:589–601. 2006.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Vicari G, Bauer SR, Neuner EA and Lam SW:
Association between colistin dose and microbiologic outcomes in
patients with multidrug-resistant gram-negative bacteremia. Clin
Infect Dis. 56:398–404. 2013.PubMed/NCBI View Article : Google Scholar
|
